Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02191020Completed
Randomised, double-blind trial of total glucosides of paeony in Psoriasis vulgaris (PV) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Reduction in Psoriasis Area and Severity Index at 12 weeks. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02191020.